Recombinant Human Erythropoietin and Overall Survival in Cancer Patients: Results of a Comprehensive Meta-analysis
暂无分享，去创建一个
[1] Brian Leyland-Jones,et al. Breast cancer trial with erythropoietin terminated unexpectedly. , 2003, The Lancet. Oncology.
[2] J. Nortier,et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] V. Hasselblad,et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. , 2001, Journal of the National Cancer Institute.
[4] C. Rübe,et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial , 2003, The Lancet.
[5] G. Schwarzer,et al. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. , 2005, Journal of the National Cancer Institute.